IL161409A0 - Methods for ligand discovery - Google Patents
Methods for ligand discoveryInfo
- Publication number
- IL161409A0 IL161409A0 IL16140902A IL16140902A IL161409A0 IL 161409 A0 IL161409 A0 IL 161409A0 IL 16140902 A IL16140902 A IL 16140902A IL 16140902 A IL16140902 A IL 16140902A IL 161409 A0 IL161409 A0 IL 161409A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- ligand discovery
- ligand
- discovery
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B20/00—Methods specially adapted for identifying library members
- C40B20/08—Direct analysis of the library members per se by physical methods, e.g. spectroscopy
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/990,421 US6919178B2 (en) | 2000-11-21 | 2001-11-21 | Extended tethering approach for rapid identification of ligands |
| US10/121,216 US6998233B2 (en) | 1998-06-26 | 2002-04-10 | Methods for ligand discovery |
| PCT/US2002/013061 WO2003046200A2 (en) | 2001-11-21 | 2002-04-24 | Methods for ligand discovery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161409A0 true IL161409A0 (en) | 2004-09-27 |
Family
ID=26819229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16140902A IL161409A0 (en) | 2001-11-21 | 2002-04-24 | Methods for ligand discovery |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050142614A1 (ru) |
| EP (2) | EP1939625A3 (ru) |
| JP (3) | JP4391237B2 (ru) |
| AU (2) | AU2002254725A1 (ru) |
| CA (1) | CA2464094C (ru) |
| IL (1) | IL161409A0 (ru) |
| MX (1) | MXPA04004814A (ru) |
| NZ (1) | NZ532579A (ru) |
| RU (1) | RU2295518C2 (ru) |
| WO (1) | WO2003046200A2 (ru) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335155B1 (en) * | 1998-06-26 | 2002-01-01 | Sunesis Pharmaceuticals, Inc. | Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules |
| US7214487B2 (en) | 1998-06-26 | 2007-05-08 | Sunesis Pharmaceuticals, Inc. | Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates |
| US6919178B2 (en) * | 2000-11-21 | 2005-07-19 | Sunesis Pharmaceuticals, Inc. | Extended tethering approach for rapid identification of ligands |
| WO2003081210A2 (en) | 2002-03-21 | 2003-10-02 | Sunesis Pharmaceuticals, Inc. | Identification of kinase inhibitors |
| WO2006027711A2 (en) * | 2004-08-26 | 2006-03-16 | Nicholas Piramal India Limited | Prodrugs and codrugs containing bio- cleavable disulfide linkers |
| EP2081435B1 (en) | 2006-09-22 | 2016-05-04 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| EP2560007A1 (en) * | 2007-03-28 | 2013-02-20 | Pharmacyclics, Inc. | Identification of bruton's tyrosine kinase inhibitors |
| US20120101113A1 (en) | 2007-03-28 | 2012-04-26 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
| EP3311818A3 (en) | 2008-07-16 | 2018-07-18 | Pharmacyclics, LLC | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
| CN102405284B (zh) * | 2008-09-05 | 2016-01-20 | 新基阿维罗米克斯研究公司 | 设计不可逆抑制剂的算法 |
| RU2012114902A (ru) | 2009-09-16 | 2013-10-27 | Авила Терапьютикс, Инк. | Конъюгаты и ингибиторы протеинкиназы |
| CA2785738A1 (en) | 2009-12-30 | 2011-07-07 | Avila Therapeutics, Inc. | Ligand-directed covalent modification of protein |
| EP2560686A2 (en) | 2010-04-21 | 2013-02-27 | Novo Nordisk A/S | Selective modification of proteins |
| WO2011153514A2 (en) | 2010-06-03 | 2011-12-08 | Pharmacyclics, Inc. | The use of inhibitors of bruton's tyrosine kinase (btk) |
| WO2013010136A2 (en) | 2011-07-13 | 2013-01-17 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
| US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| NZ702548A (en) | 2012-06-04 | 2015-11-27 | Pharmacyclics Llc | Crystalline forms of a bruton’s tyrosine kinase inhibitor |
| JP6575950B2 (ja) | 2012-07-24 | 2019-09-18 | ファーマサイクリックス エルエルシー | Ｂｒｕｔｏｎ型チロシンキナーゼ（Ｂｔｋ）阻害剤に対する耐性を伴う変異 |
| MX2015006168A (es) | 2012-11-15 | 2015-08-10 | Pharmacyclics Inc | Compuestos de pirrolopirimidina como inhibidores de quinasas. |
| JP6800750B2 (ja) | 2013-08-02 | 2020-12-16 | ファーマサイクリックス エルエルシー | 固形腫瘍の処置方法 |
| CA2920534A1 (en) | 2013-08-12 | 2015-02-19 | Pharmacyclics Llc | Methods for the treatment of her2 amplified cancer |
| PE20160560A1 (es) | 2013-09-30 | 2016-06-09 | Pharmacyclics Llc | DERIVADOS DE PIRAZOLO[3,4-d]PIRIMIDIN COMO INHIBIDORES IRREVERSIBLES DE LA TIROSINA CINASA DE BRUTON (BTK) |
| US9885086B2 (en) | 2014-03-20 | 2018-02-06 | Pharmacyclics Llc | Phospholipase C gamma 2 and resistance associated mutations |
| US9533991B2 (en) | 2014-08-01 | 2017-01-03 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
| JP2017523206A (ja) | 2014-08-07 | 2017-08-17 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の新規製剤 |
| BR122023020985A2 (pt) | 2015-03-03 | 2023-12-26 | Pharmacyclics Llc | Formulação de comprimido sólido de um inibidor de tirosina quinase de bruton |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5367058A (en) * | 1993-08-25 | 1994-11-22 | Becton, Dickinson And Company | Modified antibodies with increased affinity |
| US5361058A (en) * | 1993-11-02 | 1994-11-01 | Gould Electronics Inc. | Time delay fuse |
| US6344330B1 (en) * | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
| CA2430234C (en) * | 2000-11-21 | 2008-02-12 | Sunesis Pharmaceuticals, Inc. | An extended tethering approach for rapid identification of ligands |
-
2002
- 2002-04-24 JP JP2003547631A patent/JP4391237B2/ja not_active Expired - Fee Related
- 2002-04-24 CA CA2464094A patent/CA2464094C/en not_active Expired - Fee Related
- 2002-04-24 RU RU2004119036/04A patent/RU2295518C2/ru not_active IP Right Cessation
- 2002-04-24 EP EP08006555A patent/EP1939625A3/en not_active Withdrawn
- 2002-04-24 EP EP02723967A patent/EP1446496A4/en not_active Withdrawn
- 2002-04-24 MX MXPA04004814A patent/MXPA04004814A/es active IP Right Grant
- 2002-04-24 IL IL16140902A patent/IL161409A0/xx unknown
- 2002-04-24 WO PCT/US2002/013061 patent/WO2003046200A2/en active Application Filing
- 2002-04-24 AU AU2002254725A patent/AU2002254725A1/en not_active Abandoned
- 2002-04-24 NZ NZ532579A patent/NZ532579A/en not_active IP Right Cessation
-
2005
- 2005-02-09 US US11/054,754 patent/US20050142614A1/en not_active Abandoned
-
2009
- 2009-01-30 JP JP2009020721A patent/JP2009109515A/ja not_active Withdrawn
- 2009-07-22 AU AU2009202965A patent/AU2009202965A1/en not_active Abandoned
-
2011
- 2011-02-25 JP JP2011040912A patent/JP2011140497A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20050142614A1 (en) | 2005-06-30 |
| EP1939625A3 (en) | 2008-09-03 |
| CA2464094C (en) | 2013-07-02 |
| NZ532579A (en) | 2006-11-30 |
| JP2011140497A (ja) | 2011-07-21 |
| MXPA04004814A (es) | 2004-08-11 |
| JP2005510574A (ja) | 2005-04-21 |
| WO2003046200A3 (en) | 2003-07-24 |
| AU2002254725A1 (en) | 2003-06-10 |
| CA2464094A1 (en) | 2003-06-05 |
| RU2004119036A (ru) | 2005-05-27 |
| JP2009109515A (ja) | 2009-05-21 |
| EP1446496A4 (en) | 2005-03-30 |
| EP1446496A2 (en) | 2004-08-18 |
| WO2003046200A2 (en) | 2003-06-05 |
| AU2009202965A1 (en) | 2009-08-13 |
| EP1939625A2 (en) | 2008-07-02 |
| JP4391237B2 (ja) | 2009-12-24 |
| RU2295518C2 (ru) | 2007-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161409A0 (en) | Methods for ligand discovery | |
| EP1451156A4 (en) | 4-AMINOQUINOLINE COMPOUNDS | |
| HK1090292A1 (en) | Compounds effecting glukokinase | |
| AU2002349297A8 (en) | Statin-like compounds | |
| GB0101996D0 (en) | Organtic compounds | |
| GB0112324D0 (en) | Compounds | |
| IL162242A0 (en) | Azaindolylalkylamine derivatives as5-hydroxytryptamine-6 ligands | |
| GB0102668D0 (en) | Compounds | |
| GB0108475D0 (en) | New compounds | |
| GB0119474D0 (en) | Compounds | |
| GB0102673D0 (en) | Compounds | |
| GB0102665D0 (en) | Compounds | |
| GB0119472D0 (en) | Compounds | |
| GB0115841D0 (en) | Ligand | |
| EP1458669A4 (en) | ACTIVE COMPOUNDS ON THE NEUROLOGICAL PLAN | |
| GB0118364D0 (en) | Compounds | |
| GB0115178D0 (en) | Compounds | |
| GB0119473D0 (en) | Compounds | |
| GB0105098D0 (en) | Compounds | |
| GB0114144D0 (en) | Location discovery | |
| GB0102417D0 (en) | Location Discovery | |
| AU2001278758A1 (en) | Ligands | |
| HU0103282D0 (en) | Round-sewing-machine for haemorrhoidectomy | |
| HUP0102279D0 (en) | New compounds | |
| GB0117780D0 (en) | New compounds |